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Background and aims: Toll-like receptor 4 and CD14 are the components of the lipopolysaccharide
receptor complex. The aim of this study was to investigate the associations between polymorphisms TLR4
Asp299Gly and CD14 C-260T and Chinese patients with ulcerative colitis (UC).
Methods: Using a polymerase chain reaction based restriction fragment length polymorphism, the study
genotyped polymorphisms TLR4 Asp299Gly and CD14 C-260T in 114 patients with UC and 160 healthy
controls in the Chinese Han population. Moreover a comparison was made with 170 healthy Dutch white
subjects.
Results: No TLR4 Asp299Gly mutation was detected in any patients or healthy controls in the Chinese Han
population, which was similar to Japanese subjects, but the mutation occurred in 10% of the Dutch white
subjects. There were no significant differences of CD14 genotypes between healthy controls and the
patients with UC.
I
nflammatory bowel disease (IBD) comprises mainly
ulcerative colitis (UC) and Crohn’s disease (CD) charac-
terised by long term intestinal inflammation attributable to
an exaggerated immune response. The aetiology is still
unknown. Genetic susceptibility has been shown by epide-
miological and genetic investigations.1 Recent genome-wide
linkage studies and case-control association studies have
shown several susceptibility regions for IBD and identified
the CARD15 (NOD2), the first susceptibility gene for CD.
NOD2 is a cytosolic protein expressed in monocytes and
involved in the immune response to peptidoglycan (MDP) via
the activation of NF-kB.2–5 The studies confirm that IBD is a
complex polygenic disease and linked the disease to bacteria
and the innate immunity.
Recently, base-pair changes in the genes for both CD14 and
toll-like receptor 4 (TLR4) have been described in humans.
The LPS induced signalling through TLR4 and coreceptors
CD14 as well as LPS binding protein (LBP) leads to NF-kB
activation and cytokine expression.6 Two members of the
TLRs family have been identified as an important link
between innate and adaptive mucosal immune responses.7
TLR2 and TLR4 are suggested to be the main mediator of
innate immune responses to LPS in vitro and in vivo. It seems
that TLR4 is a principal signal transducer for LPS and TLR2 is
a signal transducer for Gram positive bacterial components
such as peptidoglycan lipopeptides and zymosan and certain
structural variants of LPS.8 9 Mutations in the TLR4 receptor
at residues 299 and 399 have been shown to be associated
with hyporesponsiveness to inhaled endotoxin or LPS in
humans.10 One of these missense polymorphisms in the
fourth exon of TLR4 Asp299Gly changed the extracellular
domain of the receptor. The mutation of TLR4 in mice was
also shown to abolish responses to endotoxin, and to be
hypersusceptible to Gram negative bacterial infection and to
be insensitive to the LPS.11 12 Cario et al13 showed that normal
intestinal epithelial cells and mucosa constitutively expressed
TLR3 and TLR5 and hardly expressed TLR2 and TLR4, but
TLR4 was strongly upregulated in both UC and CD. The
results suggested that TLR4 might have a function in protein
level in IBD. The study from Japan mentioned that there is no
relation between TLR4 Asp299Gly and IBD.14 They did not
detect any mutation of TLR4 Asp299Gly polymorphism in
IBD patients whereas two other papers have reported their
positive relation in Europe. Franchimont et al15 have shown
that TLR4 Asp299gly polymorphism was associated with CD
and UC in Belgium, and Torok et al16 also found the Thr399Ile
mutation in TLR4 gene was significantly increased in UC
when compared with the controls and reported this novel
association between a functional polymorphism in TLR4 and
UC in Germany. These studies have prompted us to study the
relation between TLR4 and UC in Chinese patients.
CD14, a GPI anchored glycoprotein expressed in mono-
cytes/macrophages and neutrophils, not in B lymphocytes or
endothelial cells, reacts efficiently with LPS complexed with
LBP in serum to activate macrophages.17 CD14 transfers LPS
and other bacterial ligands (for example, peptidoglycans and
lipoteichoic acid) from circulating LBP to the TLR4–MD-2
signalling complex.18 19 Binding LPS to membrane bound
CD14 results in cellular activation as well as the production of
proinflammatory cytokines, oxygen free radicals, nitric
oxygen, and anti-inflammatory cytokines,20 and the upregu-
lation of costimulatory molecules, which may lead to the
adaptive immune response.21 LPS responsive cells, which do
not contain membrane bound CD14 (mCD14), such as
epithelial cells, become sensitive to low concentrations of
LPS in the presence of soluble CD14 (sCD14).22 Recently a
polymorphism in the promoter region of the CD14 gene has
been reported. This polymorphism entails a TRC substitution
that is located at position 2260 when a HaeIII restriction site
is introduced.23 The identical polymorphism has also been
identified in another study, but was referred to as 2159
because of a different position when starting numbering. A
study shows that subjects carrying the T allele have
significantly higher sCD14 levels than carriers of the C
Abbreviations: UC, ulcerative colitis; CD, Crohn’s disease; IBD,
inflammatory bowel disease; TLR4, toll-like receptor 4; LBP, LPS binding
protein
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allele.24 Two papers25 26 have reported on the association
between IBD and the polymorphism CD14 C-260T, but one is
associated with UC while the other is associated with CD.
Moreover, Torok et al16 have reported that they did not find
the association between the CD14 promoter polymorphism
and UC. Different results might be interpreted by genetic
heterogeneity of races.
These studies investigated the possible role of TLR4/CD14
genes in LPS binding and signalling. We hypothesised that
polymorphisms of the TLR4 and the CD14 gene may be
important factors for determining susceptibility to UC and
may be predictive for the disease outcome. To evaluate
whether these two polymorphisms contribute to the predis-
position to UC, we detected TLR4 and CD14 gene polymorph-
isms in Chinese patients with UC.
METHODS
Subjects
One hundred and fourteen patients with UC from Zhongnan
Hospital of Wuhan University and other central hospitals in
Wuhan city were studied. Diagnosis of UC was made by
conventional clinical, radiological, endoscopic, and histologi-
cal criteria.27 The patients with UC were classified according
to sex (male and female) and location (left sided colitis,
proctitis, and extensive colitis). Ethnically matched 160
Chinese healthy controls and 170 Dutch white healthy
controls were recruited from staff and students in Wuhan
University Zhongnan Hospital and Vrije Universiteit Medical
Centre, Amsterdam, Netherlands (VUmc), respectively. All
Chinese subjects were unrelated Han Chinese, and Dutch
participants were the unrelated white subjects. All the
subjects gave informed consents. The study protocol was
approved by the ethics committee of Wuhan University
Medical School.
DNA isolation
Genomic DNA was isolated from 5 ml EDTA anticoagulated
venous blood by conventional proteinase K digestion and
phenol/chloroform extraction method. The positive control
DNA samples of TLR4 and CD14 genes were provided by the
laboratory of immunogenetics of VUmc.
TLR4 Asp299Gly genotyping
The two primer sets were designed from the TLR4 coding
sequence (GenBank accession no U88880) referenced to
Okayama et al14 (F1: 5’-TTAGAAATGAAGGAAACTTGGAAA
AG-3’, R1: 5’-TTTGTCAAACAATTAAATAAGTGATTAATA-3’,
F2: 5’-AGCATACTTAGACTACCACCTCGATG-3’, R2: 5’-GTT
GCCATCCGAAATTATAAGAAAAG-3’). The PCR conditions
were as follows: an initial denaturation at 94 C˚ for three
minutes, followed by 38 cycles of denaturing at 94 C˚ for
45 seconds, annealing at 51 C˚ for 45 seconds, and extension
at 72 C˚ for 45 seconds. The final extension was continued at
72 C˚ for five minutes and cooling to 4 C˚. The PCR was
performed using a total 25 ml of the following mixture:
50 pmol of each primer, 2.5 ml of 106buffer, 1.5 ml of 25 mM
MgCl2, 0.5 ml of 10 mM dNTPs, 1 ml of template DNA, 1 ml of
AmpliTaq DNA polymerase (MBI Fermentas), and 13.5 ml
ddH2O. The amplification was carried out on a Perkin-Elmer
thermal cycler. PCR products were analysed by electrophor-
esis in 2% agarose gel with ethidium bromide staining under
ultraviolet transillumination.
To detect the mutation in the TLR4 fragments, the PCR
based restriction fragment length polymorphism (RFLP)
analysis was performed. The PCR products were digested by
the restriction enzymes BsaBI and BstXI. The 139 bp PCR
product was amplified by F1 and R1, and the 131 bp
fragment was amplified by F2 and R2. When digested by
BsaBI, the fragments (139 bp for allele G and 112 bp +27 bp
for allele A respectively) were obtained. When digested by
BstXI, the fragments (108 bp +23 bp for allele G and 131 bp
for allele A) were obtained. The products were separated by
electrophoresis in non-denaturing polyacrylamide gels con-
taining 8% acrylamide-bisacrylamide (29:1), 0.56 TRIS-
borate-EDTA (TBE), 10% ammonium persulphate, and
TEMED at 150 V for 1.5 hours. The gels were then subjected
to silver staining.
CD14 genotyping
Primers of CD14 P1 (5’-CCTGCAGAATCCTTCCTGTT-3’) and
CD14 P2 (5’-TCACCTCCCCACCTCTCTT-3’) were used to
amplify a 107 bp fragment of the CD14 promoter (GenBank
accession no U00699). A 25 ml PCR amplification mixture
containing 50 pmol of each primer, 2.5 ml of 106buffer, 1.5 ml
of 25 mM MgCl2, 0.5 ml of 10 mM dNTPs, 1 ml of template
DNA, 1 ml of AmpliTaq DNA polymerase, and 17 ml ddH2O,
was run in a Perkin-Elmer Thermal cycler. After an initial
denaturation at 94 C˚ for five minutes, 35 cycles of denaturing
at 94 C˚ for 30 seconds, annealing at 55 C˚ for 30 seconds, and
extension at 72 C˚ for one minute followed. The final
extension was continued at 72 C˚ for seven minutes and kept
in 4 C˚. PCR products were analysed by electrophoresis in 2%
agarose gel with ethidium bromide staining under ultraviolet
transillumination. The C allele of the polymorphism of CD14
at position 2260 contains the restriction site for Hae III,
which is not present in the T allele. The PCR was restricted
with Hae III and the resulting fragments (107 bp for the T
allele and 83 bp and 24 bp for the C allele, respectively) were
separated on non-denaturing polyacrylamide gels containing
8% acrylamide-bisacrylamide and then silver staining.
Statistics analysis
The data were analysed using SPSS software (version 11.0,
SPSS, Chicago, IL). Genotypes and allele frequencies were
calculated by direct counting. Significance of the association
was determined by x2 test and Fisher’s exact test. Departures
from Hardy-Weinberg equilibrium were tested by the x2
method. A value of p,0.05 was considered significant. Odds
ratios (OR) with 95% confidence intervals (95% CI) were
calculated according to Woolf’s method.
RESULTS
In our study, the functional mutation Asp299Gly of the TLR4
gene was not detected in any Chinese subject. All the PCR
products were sensitive to BsaBI and resistant to BstXI, they
were all wild-type homozygotes. Therefore, significant
association was not seen in patients with UC and healthy
controls in the Chinese subjects, which is similar to the
results in Japanese.14 However, mutations TLR4 Asp299Gly
occurred in 10% of the Dutch subjects.
The distributions of genotype and allele frequencies of
CD14 C-260T in both the patients and the healthy controls
Table 1 Genotypes and allele frequencies of CD14 C-
260T in healthy controls and patients with ulcerative colitis
(UC) in the Chinese Han population
Healthy controls (n = 160) UC (n = 114)
Genotype Number (%) Number (%)
T/T 58 (36.3) 42 (36.8)
C/T 77 (48.1) 62 (54.4)
C/C 25 (15.6) 10 (8.8)
Allele frequency % %
T 60.3 64.0
C 39.7 36.0
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were in Hardy-Weinberg equilibrium (table 1). Frequencies
of C/C genotype in healthy controls and UC were 15.6% and
8.8%, respectively, and frequencies of C/T genotype were
48.1% and 54.4%, respectively. The distribution of genotypes
of the CD14 C-260T was not statistically different among the
healthy controls and the patients with UC in the Chinese
(p=0.2267). In table 2, no significant differences were found
in the genotype and allele frequencies of the CD14-260T
among subgroups of UC, which were stratified according to
sex and location of the disease. Furthermore, CD14 C-260T
genotypes differed significantly in Chinese from Japanese,29
and from Dutch populations28 (table 3).
DISCUSSION
This study has shown that the G allele of TLR4 gene
Asp299Gly was not present in the Chinese population tested.
Therefore, we could not find any association between the
TLR4 Asp299Gly mutated genotype and UC, similar to a study
in the Japanese.14 They genotyped 108 healthy volunteers and
50 patients with UC and did not detect any mutation of the
TLR4 Asp299Gly. Comparing the genotype and allele fre-
quencies of the TLR4 Asp299Gly polymorphism among
Chinese, Japanese,14 and Dutch white subjects,28 we found
significant differences between Asians and Dutch white
subjects. In Chinese and Japanese, the mutation of the TLR4
Asp299Gly did not occur, while in Dutch white subjects, the
combination of AG and GG genotypes occurred in 10%. Our
study showed that the distribution of the TLR4 Asp299Gly
polymorphism was significantly different between Asia and
this western population.
CD14, the coreceptor of TLR4 for LPS, is present in two
forms, mCD14 and sCD14.30 31 Membrane CD14 is expressed
on the surface of monocytes and macrophages and activates
through TLR4, while sCD14 facilitates the LPS binding to the
cells that do not express mCD14. CD14 gene is located on the
long arm of chromosome 5 (5q31–33) and consists of a single
base substitution (CRT) at position 2260 in the promoter of
the CD14 gene. This polymorphism has been reported to
influence the density of CD14 expression on monocytes for
the activation of monocytes to secrete inflammatory cyto-
kines by LPS.23 The T variant of the 2260 polymorphism can
promote the transcription of CD14 gene and cause higher
expression of CD14 on monocytes, which may lead to an
increased inflammatory response. Furthermore, subjects
carrying the T allele have significantly higher soluble CD14
levels than carriers of the C allele. Therefore, the CD14
polymorphism may be a genetic factor responsible for
individual differences in the expression of CD14 and
inflammatory response to luminal bacterial infections.
Zareie et al32 found that intestinal lamina propria mono-
nuclear cells (LPMCs) of patients with CD were sponta-
neously activated by LPS. Active intestinal inflammation in
IBD patients has shown increased expression of CD14 in
LPMCs.33 34 Therefore, activation of the CD14 pathway in
LPMCs or intestinal epithelium may be a trigger in the
inflammatory response leading to increased production of
proinflammatory cytokines and mucosal damage. Two
clinical studies have shown an association between poly-
morphism in the promoter of the CD14 gene and myocardial
infarction.23 35 One Japanese research group confirmed that
the C-260T polymorphism in the promoter of the CD14
monocyte receptor gene was associated with acute myocar-
dial infarction rather than with coronary atherosclerosis.36
Eng et al37 found an association between Chlamydia pneumo-
niae infection and CD14 polymorphism in the Chinese
population in Taiwan. Linkage between CD14 polymorphism
and IBD has also been studied. In a German population, an
association of CD with allele T and the T/T genotype of CD14
gene has been found significant, which may be interpreted by
a changed immune response to LPS contributing to the
genetic predisposition to CD but not to UC.25 However, it has
been shown that the CD14 gene in 5q31–33 region had a
significant linkage with UC in the Japanese population26 and
in the Canadian population.28
Our study has shown that CD14 C-260T polymorphism was
not associated with UC in the Chinese population. The
frequency of the C/C genotype in healthy controls (15.6%)
was higher than in UC (8.8%), the C/T genotype in UC
(54.4%) was higher than in healthy controls (48.1%), but
neither of them is statistically significant. We did not find
differences of CD14 C-260T between subgroups of UC as
shown in table 2. Furthermore, the distributions of CD14 C-
260T genotypes were significantly different Chinese and
Japanese,29 and between Chinese and Dutch white subjects28
(table 3), which demonstrated ethnic genetic differences. The
study implicates that the polymorphism of CD14 C-260T does
not confer a genetic predisposition to UC. The lack of
association of CD14 gene with UC in the Chinese population
may be explained by genetic heterogeneity, and possibly a type 2
statistical error.
In summary, both the polymorphism of CD14 C-260T and
TLR4 Asp299Gly were not associated with UC in the Chinese
population, but the distributions of these two gene poly-
morphisms have ethnic differences.
Table 2 Genotype and allele frequencies of CD14 C-260T classified by sex and location
of ulcerative colitis in Chinese patients
Genotype frequency (%) Allele frequency (%)
T/T C/T C/C T C
Sex
Male (n = 64) 23 (35.9) 37 (57.8) 4 (6.3) 83 (64.8) 45 (35.2)
Female (n = 50) 19 (38.0) 25 (50.0) 6 (12.0) 63 (63.0) 37 (37.0)
Location
Left sided colitis (n = 51) 20 (39.2) 25 (49.0) 6 (11.8) 65 (63.7) 37 (36.3)
Proctitis(n = 19) 2 (10.5) 10 (52.6) 7 (36.9) 14 (36.8) 24 (63.2)
Extensive colitis (n = 44) 2 (4.5) 27 (61.4) 15 (34.1) 31 (35.2) 57 (64.8)
Table 3 Genotypes of CD14 C-260T in Chinese,
Japanese, and Dutch population
Chinese
(n = 160)
Japanese29
(n = 527)
Dutch28
(n = 170)
T/T 58 (36.3) 134 (25.4) 40 (24)
T/C 77 (48.1) 278 (52.8) 82 (48)
C/C 25 (15.6) 115 (21.8)* 48 (28)
*Chinese v Japanese: x2 (362 table): 7.965, p = 0.0186; Chinese v
Dutch: x2 (362 table): 10.416, p = 0.0055.
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